{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:24:34Z","timestamp":1783445074060,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajo.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:04:47Z","timestamp":1778627087000},"page":"305-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-4815","authenticated-orcid":false,"given":"Nikhil","family":"Dav\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. Taylor","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Cernichiaro-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3276-6930","authenticated-orcid":false,"given":"Benjamin A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0652-4190","authenticated-orcid":false,"given":"Matthew W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2026.05.005_bib0001","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS Report no. 10","volume":"125","author":"The Collaborative Ocular Melanoma Study Group","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.005_bib0002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archopht.1997.01100160056009","article-title":"Mortality in patients with small choroidal melanoma. COMS Report no. 4","volume":"115","author":"The Collaborative Ocular Melanoma Study Group","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.005_bib0003","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.005_bib0004","first-page":"93","article-title":"The Eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"Personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.005_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.005_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clindermatol.2023.10.005","article-title":"The cancer genome atlas for uveal melanoma is predictive of patient outcomes","volume":"42","author":"Bas","year":"2024","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.005_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.005_bib0008","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.005_bib0009","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.4103\/ijo.IJO_1589_19","article-title":"Prognostication of uveal melanoma is simple and highly predictive using the cancer genome atlas (TCGA) classification: a review","volume":"67","author":"Shields","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"28","key":"10.1016\/j.ajo.2026.05.005_bib0010","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-Gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2026.05.005_bib0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2018.07.045","article-title":"Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma","volume":"195","author":"Cai","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.005_bib0012","doi-asserted-by":"crossref","unstructured":"Augsburger JJ, Gamel JW, Shields JA, Markoe AM, Brady LW Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology. 1987;94(9):1173-7. doi:10.1016\/s0161-6420(87)33310-x.","DOI":"10.1016\/S0161-6420(87)33310-X"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.005_bib0013","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjo.2003.036285","article-title":"Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma","volume":"88","author":"Kaiserman","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.005_bib0014","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ophtha.2017.04.013","article-title":"Association between tumor regression rate and gene expression profile after Iodine 125 plaque radiotherapy for Uveal melanoma","volume":"124","author":"Mruthyunjaya","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.005_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/23258160-20150323-06","article-title":"Gene expression profiling and regression rate of irradiated uveal melanomas","volume":"46","author":"Rao","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.005_bib0016","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00417-016-3305-2","article-title":"Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height","volume":"254","author":"Gupta","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.005_bib0017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000542397","article-title":"The Association between gene expression profiling and regression rate of posterior uveal melanoma following proton beam irradiation","volume":"11","author":"Suwajanakorn","year":"2025","journal-title":"Ocul Oncol Pathol"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.005_bib0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2018.04.019","article-title":"Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread","volume":"127","author":"Mitsch","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ajo.2026.05.005_bib0019","article-title":"Efficacy of low-dose rate iodine-125 plaque brachytherapy in the treatment of uveal melanoma","author":"Cernichiaro-Espinosa","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.005_bib0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Internal Med"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.005_bib0021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3","volume":"14","author":"The Collaborative Ocular Melanoma Study Group","year":"1993","journal-title":"Cntrl Clin Trials"},{"key":"10.1016\/j.ajo.2026.05.005_bib0022","series-title":"Basic Radiat Oncol","first-page":"131","article-title":"Radiosensitivity","author":"Beyzadeoglu","year":"2010"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.005_bib0023","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archopht.1985.01050070050028","article-title":"Comparison of uveal melanoma growth rates with mitotic index and mortality","volume":"103","author":"Gass","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.005_bib0024","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","article-title":"Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study. COMS Report no. 6","volume":"125","author":"Albert","year":"1998","journal-title":"Am J Ophthal"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.005_bib0025","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.005_bib0026","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.005_bib0027","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.005_bib0028","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","article-title":"Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma","volume":"134","author":"Walter","year":"2016","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:34:45Z","timestamp":1783442085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S0002939426002394"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.005","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}